Showing results (101-110 of 286) with videos related to
Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031Soheil Meshinchi, Stephen P Hunger, Richard Aplenc, et al.Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.JHLT Open|March 27, 2025
Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantationTodd A Miano, Athena F Zuppa, Rui Feng, et al.Journal of Pediatric Hematology/Oncology|February 10, 2004
Congenital neuroblastoma arising in the deltoid muscleTammy Kang, John Dormans, John Maris, et al.Pediatric Blood & Cancer|May 21, 2010
Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium studyStacey L Berg, Naomi Winick, Ashish Mark Ingle, et al.The Pharmacogenomics Journal|June 2, 2018
Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 9, 2017
Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.Cancer|May 24, 2014
Declining childhood and adolescent cancer mortalityMalcolm A Smith, Sean F Altekruse, Peter C Adamson, et al.Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperativesBarry D Anderson, Peter C Adamson, Susan L Weiner, et al.Pageof 29